玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

VRT752271

    
99.9%

VRT752271

源葉(MedMol)
S81037 一鍵復制產品信息
869886-67-9
C21H22Cl2N4O2
433.331
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S81037-1mg
99.9% ¥240.00 10 - - -
S81037-2mg
99.9% ¥400.00 10 - - -
S81037-5mg
99.9% ¥640.00 8 - - -
S81037-10mg
99.9% ¥960.00 7 - - -
S81037-25mg
99.9% ¥1680.00 7 - - -
S81037-50mg
99.9% ¥2880.00 5 - - -
S81037-100mg
99.9% ¥4800.00 4 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line

產品描述: Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line
靶點: ERK2:0.3 nM (IC50, at KM ATP (60 μM));ERK1;ERK
體外研究: Combined Ulixertinib (BVD-523; 10, 20, 30 μM; 48 hours) and VS-5584 treatment causes significant induction of cell death in human pancreatic cancer (HPAC) cells in PDAC cell lines BxPC-3, MIAPaCa-2, and CFPAC-1
體內研究: In the pharmacokinetic study, the sensitivity and specificity of the assay are found to be sufficient for accurately characterizing the plasma pharmacokinetics of Ulixertinib (VRT752271) in Balb/C mice
參考文獻: 1. Ward RA, et al. Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2. J Med Chem. 2015 Jun 11;58(11):4790-801. 2. Kumar R, et al. Determination of ulixertinib in mice plasma by LC-MS/MS and its application to a pharmacokinetic study in mice. J Pharm Biomed Anal. 2016 Jun 5;125:140-4. 3. Changwen Ning, et al. Targeting ERK Enhances the Cytotoxic Effect of the Novel PI3K and mTOR Dual Inhibitor VS-5584 in Preclinical Models of Pancreatic Cancer. Oncotarget. 2017 Jul 4;8(27):44295-44311.
溶解性: soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.308 ml 11.539 ml 23.077 ml
5 mM 0.462 ml 2.308 ml 4.615 ml
10 mM 0.231 ml 1.154 ml 2.308 ml
50 mM 0.046 ml 0.231 ml 0.462 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 阿拉尔市| 沾化县| 得荣县| 博野县| 丁青县| 新田县| 盐山县| 陕西省| 霍城县| 平南县| 珲春市| 夏邑县| 黑龙江省| 永顺县| 龙海市| 惠州市| 皮山县| 南郑县| 河东区| 突泉县| 信宜市| 乐昌市| 施秉县| 容城县| 大渡口区| 鄂州市| 西青区| 育儿| 许昌市| 成都市| 托克托县| 江安县| 泰来县| 海宁市| 白城市| 遂宁市| 赤水市| 清水县| 星座| 岗巴县| 湄潭县|